Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation.
暂无分享,去创建一个
B. Ebert | M. Ducar | A. Thorner | J. Ritz | S. Nikiforow | W. Lane | E. Morgan | R. Soiffer | Bruce Wollison | Jordan Wengrod | R. Lindsley | C. Cutler | Samantha D. Drinan | J. Antin | V. Ho | E. Alyea | N. Kekre | M. Jan | J. Koreth | Anwesha Nag | S. Leppanen | Jonathan Stevens | Matthew J. Leventhal | Jane Baronas | Max Jan | R. C. Lindsley
[1] G. Tonon,et al. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation , 2019, Nature Medicine.
[2] Christopher A. Miller,et al. Immune Escape of Relapsed AML Cells after Allogeneic Transplantation , 2018, The New England journal of medicine.
[3] W. J. Valente,et al. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA , 2018, Nature Communications.
[4] Christopher A. Miller,et al. Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant. , 2018, JCI insight.
[5] Angela E. Leek,et al. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution , 2017, Cell.
[6] D. Neuberg,et al. Prognostic Mutations in Myelodysplastic Syndrome after Stem‐Cell Transplantation , 2017, The New England journal of medicine.
[7] S. Miyano,et al. Dynamics of clonal evolution in myelodysplastic syndromes , 2016, Nature Genetics.
[8] T. Graeber,et al. Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma. , 2016, The New England journal of medicine.
[9] R. Beroukhim,et al. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. , 2016, Neuro-oncology.
[10] Eric S. Lander,et al. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma , 2016, Cell reports.
[11] J. McQuade,et al. Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy. , 2016, Cancer discovery.
[12] H. Aburatani,et al. Integrated molecular analysis of adult T cell leukemia/lymphoma , 2015, Nature Genetics.
[13] S. Miyano,et al. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. , 2015, The New England journal of medicine.
[14] D. Neuberg,et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. , 2015, Blood.
[15] N. Hacohen,et al. Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity , 2015, Cell.
[16] M. Marcatti,et al. Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation , 2014, Leukemia.
[17] E. Spierings. Minor histocompatibility antigens: past, present, and future. , 2014, Tissue antigens.
[18] Benjamin Schubert,et al. OptiType: precision HLA typing from next-generation sequencing data , 2014, Bioinform..
[19] I. Weissman,et al. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission , 2014, Proceedings of the National Academy of Sciences.
[20] M. Neale,et al. Whole exome sequencing to estimate alloreactivity potential between donors and recipients in stem cell transplantation , 2014, British journal of haematology.
[21] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[22] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[23] C. Bordignon,et al. Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT. , 2012, Blood.
[24] B. Seliger,et al. Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation , 2012, Transplantation.
[25] A. Tichelli,et al. Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy , 2012, Leukemia.
[26] S. Ogawa,et al. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia. , 2011, Blood.
[27] J. Finke,et al. Genome-wide profiling in AML patients relapsing after allogeneic hematopoietic cell transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[28] Raul Rabadan,et al. Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma , 2011, Nature Genetics.
[29] A. McKenna,et al. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.
[30] S. Ogawa,et al. Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation. , 2010, Blood.
[31] K Holzmann,et al. Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis , 2010, Leukemia.
[32] Federica Torri,et al. Loss of mismatched HLA in leukemia after stem-cell transplantation. , 2009, The New England journal of medicine.
[33] C. Chelala,et al. Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia , 2008, Genes, chromosomes & cancer.
[34] S. Dermime,et al. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation , 1997, Bone Marrow Transplantation.
[35] Daniel Rios,et al. Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .